Saizo Fujimoto, Koji Hatano, Eri Banno, Daisuke Motooka, Marco Antonio De Velasco, Yurie Kura, Shingo Toyoda, Mamoru Hashimoto, Shogo Adomi, Takafumi Minami, et al. Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men. Cancer science. 2025. 116. 2. 462-469
Mitsuhisa Nishimoto, Marco A De Velasco, Yutaka Yamamoto, Saizo Fujimoto, Yasunori Akashi, Shingo Toyoda, Mamoru Hashimoto, Shogo Adomi, Eri Banno, Yoshitaka Saito, et al. Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate. The Prostate. 2025. e24865
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Mamoru Hashimoto, et al. Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium. International journal of clinical oncology. 2025
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Saizo Fujimoto, et al. Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium. International journal of clinical oncology. 2025. 30. 1. 123-133
2015/03 - EAU Best Poster A phase-II study of peptide vaccines and dexamethasone vs dexamethasone alone for chemotherapy-naive castration resistant prostate cancer- a final report